Topical 0.03% Tacrolimus for Treatment of Pemphigus Erythematosus in a Korea Jindo Dog

Topical 0.03% tacrolimus was used for treatment of a Korea Jindo dog diagnosed with pemphigus erythematosus. The dog was slowly improved following application of tacrolimus but did not achieve complete remission until end of this study. No adverse effects on clinical or laboratory parameters were noted during the topical tacrolimus therapy period.This work was supported by the Brain Korea 21 Program for Veterinary Science. Further support was also provided by the Research Institute of Vet-erinary Science, College of Veterinary Medicine, Seoul National University, and a Korean Research Foundation Grant (KRF-2006–005-J02902)